Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1993. Start Trial.
Date Value
June 30, 2026 52.64%
March 31, 2026 53.05%
December 31, 2025 53.50%
September 30, 2025 52.05%
June 30, 2025 52.74%
March 31, 2025 52.56%
December 31, 2024 51.01%
September 30, 2024 51.02%
June 30, 2024 51.12%
March 31, 2024 50.40%
December 31, 2023 51.34%
September 30, 2023 49.63%
June 30, 2023 49.56%
March 31, 2023 49.30%
December 31, 2022 49.26%
September 30, 2022 50.04%
June 30, 2022 51.29%
March 31, 2022 53.54%
December 31, 2021 54.14%
September 30, 2021 55.45%
June 30, 2021 52.58%
March 31, 2021 53.27%
December 31, 2020 53.14%
September 30, 2020 48.93%
June 30, 2020 47.50%
Date Value
March 31, 2020 50.18%
December 31, 2019 52.72%
September 30, 2019 52.13%
June 30, 2019 52.64%
March 31, 2019 51.63%
December 31, 2018 52.58%
September 30, 2018 52.04%
June 30, 2018 51.20%
March 31, 2018 51.14%
December 31, 2017 49.82%
September 30, 2017 50.93%
June 30, 2017 46.08%
March 31, 2017 43.79%
December 31, 2016 54.70%
September 30, 2016 54.17%
June 30, 2016 54.08%
March 31, 2016 52.63%
December 31, 2015 53.74%
September 30, 2015 53.36%
June 30, 2015 53.77%
March 31, 2015 53.99%
December 31, 2014 53.04%
September 30, 2014 51.80%
June 30, 2014 51.90%
March 31, 2014 49.89%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Becton, Dickinson & Co. 46.46%
Boston Scientific Corp. 66.50%
DexCom, Inc. 63.44%
Globus Medical, Inc. 65.92%
Intuitive Surgical, Inc. 67.76%